The company
BioOrbit is space manufacturing company developing hardware for the large-scale crystallisation of protein drugs.
The funding
BioOrbit, based in London, United Kingdom, announced £9.8M in Seed financing on April 30, 2026.
Participants include Type One Ventures, LocalGlobe, Seedcamp, Auxxo, Breega, 7 percent.